# A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

> **NCT00439881** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (—)

## Conditions studied

- Arthritis, Rheumatoid
- Inflammation

## Interventions

- **DRUG:** SB-681323

## Key facts

- **NCT ID:** NCT00439881
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 16 (—)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439881, "A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00439881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*